These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 28245520

  • 21. Increased serum RANTES in patients with systemic lupus erythematosus.
    Lu MM, Wang J, Pan HF, Chen GM, Li J, Cen H, Feng CC, Ye DQ.
    Rheumatol Int; 2012 May; 32(5):1231-3. PubMed ID: 21258798
    [Abstract] [Full Text] [Related]

  • 22. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
    Arcani R, Bertin D, Bardin N, Mazodier K, Jean R, Suchon P, Venton G, Daumas A, Jean E, Villani P, Kaplanski G, Jarrot PA.
    Rheumatology (Oxford); 2021 Sep 01; 60(9):4074-4084. PubMed ID: 33404653
    [Abstract] [Full Text] [Related]

  • 23. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
    Li YN, Hu FL, Dai YJ, Li R, Ma XX, Du Y, Feng M, Jia Y, Zhang CF, Zhu L, Ascherman DP, Li ZG.
    Lupus; 2014 Aug 01; 23(9):868-75. PubMed ID: 24704774
    [Abstract] [Full Text] [Related]

  • 24. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
    Zhou Z, Xu A, Teng J, Wang F, Tan Y, Liu H, Cheng X, Su Y, Shi H, Hu Q, Chi H, Li J, Hou J, Sun Y, Yang C, Ye J.
    J Immunol Res; 2020 Aug 01; 2020():2180708. PubMed ID: 33224991
    [Abstract] [Full Text] [Related]

  • 25. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D.
    J Assoc Physicians India; 2013 Jun 01; 61(6):372-7. PubMed ID: 24640201
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjögren's syndrome.
    Tsay GJ, Wang CL, Chen TY, Huang CN, Hsu TC.
    J Formos Med Assoc; 1996 Dec 01; 95(12):905-10. PubMed ID: 9000806
    [Abstract] [Full Text] [Related]

  • 28. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Moriuchi J, Morita K, Hoshina Y, Horiki T.
    Tokai J Exp Clin Med; 1993 Dec 01; 18(3-6):133-8. PubMed ID: 7701526
    [Abstract] [Full Text] [Related]

  • 29. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
    Gupta S, Tatouli IP, Rosen LB, Hasni S, Alevizos I, Manna ZG, Rivera J, Jiang C, Siegel RM, Holland SM, Moutsopoulos HM, Browne SK.
    Arthritis Rheumatol; 2016 Jul 01; 68(7):1677-87. PubMed ID: 26815287
    [Abstract] [Full Text] [Related]

  • 30. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD, Patwardhan MM, Ghosh K.
    Indian J Dermatol Venereol Leprol; 2010 Jul 01; 76(2):145-9. PubMed ID: 20228543
    [Abstract] [Full Text] [Related]

  • 31. Serum high-mobility group box 1 is correlated with interferon-α and may predict disease activity in patients with systemic lupus erythematosus.
    Tanaka A, Ito T, Kibata K, Inagaki-Katashiba N, Amuro H, Nishizawa T, Son Y, Ozaki Y, Nomura S.
    Lupus; 2019 Aug 01; 28(9):1120-1127. PubMed ID: 31299881
    [Abstract] [Full Text] [Related]

  • 32. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P, De Andrea M, Migliaretti G, Trapani C, Landolfo S, Gariglio M.
    J Rheumatol; 2002 Jan 01; 29(1):90-3. PubMed ID: 11824977
    [Abstract] [Full Text] [Related]

  • 33. [Serum free light chains for monitoring systemic lupus erythematosus activity].
    Żychowska I, Suszek D, Dryglewska M, Nurzyńska D, Donica H, Majdan M.
    Wiad Lek; 2018 Jan 01; 71(1 pt 1):21-31. PubMed ID: 29558348
    [Abstract] [Full Text] [Related]

  • 34. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
    Su CC, Shau WY, Wang CR, Chuang CY, Chen CY.
    Lupus; 1997 Jan 01; 6(5):449-54. PubMed ID: 9229364
    [Abstract] [Full Text] [Related]

  • 35. Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.
    Koutsonikoli A, Trachana M, Farmaki E, Tzimouli V, Pratsidou-Gertsi P, Printza N, Garyphallos A, Galanopoulou V, Kanakoudi-Tsakalidou F, Papachristou F.
    Clin Exp Immunol; 2017 Apr 01; 188(1):79-85. PubMed ID: 27936517
    [Abstract] [Full Text] [Related]

  • 36. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study.
    Ren Y, Xie J, Lin F, Luo W, Zhang Z, Mao P, Zhong R, Liang Y, Yang Z.
    Int Immunopharmacol; 2018 Jul 01; 60():189-193. PubMed ID: 29747124
    [Abstract] [Full Text] [Related]

  • 37. Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?
    Cinoku I, Mavragani CP, Tellis CC, Nezos A, Tselepis AD, Moutsopoulos HM.
    Clin Exp Rheumatol; 2018 Jul 01; 36 Suppl 112(3):61-67. PubMed ID: 30156537
    [Abstract] [Full Text] [Related]

  • 38. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
    Fragoulis GE, Vakrakou AG, Papadopoulou A, Germenis A, Kanavakis E, Moutsopoulos HM, Manoussakis MN.
    J Autoimmun; 2015 Jan 01; 56():12-22. PubMed ID: 25228497
    [Abstract] [Full Text] [Related]

  • 39. HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response.
    Lu M, Yu S, Xu W, Gao B, Xiong S.
    J Immunol Res; 2015 Jan 01; 2015():946748. PubMed ID: 26078984
    [Abstract] [Full Text] [Related]

  • 40. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H, Ye J, Teng J, Yin Y, Hu Q, Wu X, Liu H, Cheng X, Su Y, Liu M, Gu J, Lu T, Chen H, Zheng H, Sun Y, Yang C.
    Arthritis Res Ther; 2017 Mar 09; 19(1):52. PubMed ID: 28274252
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.